Turn off MathJax
Article Contents
Man Yu, Ling Li, Yijun Liu, Ting Wang, Huan Li, Chen Shi, Xiaoxin Guo, Weijia Wu, Chengzi Gan, Mingze Li, Jiaxu Hong, Kai Dong, Bo Gong. Pathogenesis and Treatment Strategies for Infectious Keratitis: Exploring Antibiotics, Antimicrobial Peptides, Nanotechnology, and Emerging Therapies[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101250
Citation: Man Yu, Ling Li, Yijun Liu, Ting Wang, Huan Li, Chen Shi, Xiaoxin Guo, Weijia Wu, Chengzi Gan, Mingze Li, Jiaxu Hong, Kai Dong, Bo Gong. Pathogenesis and Treatment Strategies for Infectious Keratitis: Exploring Antibiotics, Antimicrobial Peptides, Nanotechnology, and Emerging Therapies[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101250

Pathogenesis and Treatment Strategies for Infectious Keratitis: Exploring Antibiotics, Antimicrobial Peptides, Nanotechnology, and Emerging Therapies

doi: 10.1016/j.jpha.2025.101250
  • Received Date: Aug. 19, 2024
  • Rev Recd Date: Feb. 14, 2025
  • Available Online: Mar. 03, 2025
  • Infectious keratitis (IK) is a leading cause of blindness worldwide, primarily resulting from improper contact lens use, trauma, and a compromised immune response. The pathogenic microorganisms responsible for IK include bacteria, fungi, viruses, and Acanthamoeba. This review examines standard therapeutic agents for treating IK, including broad-spectrum empiric antibiotics for bacterial keratitis (BK), antifungals such as voriconazole and natamycin for fungal infections, and antiviral nucleoside analogues for viral keratitis. Additionally, this review discusses therapeutic agents, such as polyhexamethylene biguanide (PHMB), for the treatment of Acanthamoeba keratitis (AK). The review also addresses emerging drugs and the challenges associated with their clinical application, including anti-biofilm agents that combat drug resistance and nuclear factor kappa-B (NF-κB) pathway-targeted therapies to mitigate inflammation. Furthermore, methods of Photodynamic Antimicrobial Therapy (PDAT) are explored. This review underscores the importance of integrating novel and traditional therapies to tackle drug resistance and enhance drug delivery, with the goal of advancing treatment strategies for IK.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Article Metrics

    Article views (16) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return